The ADC demonstrated anti-tumor activity in both the xenograft models and in the PDX, even if the anti-tumor activity is higher in the xenograft murine model, the levels of GPC1 being more homogeneous in comparison with the PDX model [108]. This evidence concerns the gene GPC1 and neoplasm.